RITODRINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ritodrine Hydrochloride, and when can generic versions of Ritodrine Hydrochloride launch?
Ritodrine Hydrochloride is a drug marketed by Abraxis Pharm and Hospira and is included in five NDAs.
The generic ingredient in RITODRINE HYDROCHLORIDE is ritodrine hydrochloride. There are five drug master file entries for this compound. Additional details are available on the ritodrine hydrochloride profile page.
Summary for RITODRINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 104 |
Clinical Trials: | 10 |
Patent Applications: | 466 |
Formulation / Manufacturing: | see details |
DailyMed Link: | RITODRINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for RITODRINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assiut University | Phase 3 |
Assiut University | Phase 4 |
Assiut University | N/A |